Rcadia’s COR Analyzer Family Of Products Receives Second FDA Clearance

Rcadia Medical Imaging, Ltd., developer of novel computer aided diagnostic software, has received a second U.S. Federal Food and Drug Administration (FDA) clearance to market its COR Analyzer family of products, which assists in triaging patients for coronary artery disease (CAD). The new approval includes segmentation of the coronary tree with no human intervention and automatic detection of pathologies in the main coronary arteries. [click link for full article]

More: continued here

Filed under: Cardiovascular on September 28th, 2007